| |
| |
|
| Insider
Information: |
Delfini Lisa |
| Relationship: |
Chief Financial Officer |
| City: |
New Haven |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
35,901 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
35,901 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Trevi Therapeutics, Inc. |
TRVI |
Chief Financial Officer |
2023-10-11 |
35,901 |
2023-02-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-10-11 |
4 |
AS |
$2.02 |
$1,586 |
D/D |
(785) |
35,901 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-10-11 |
4 |
OE |
$0.51 |
$1,171 |
D/D |
2,292 |
36,686 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-09-11 |
4 |
AS |
$2.20 |
$1,564 |
D/D |
(711) |
34,394 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-09-11 |
4 |
OE |
$0.51 |
$1,171 |
D/D |
2,291 |
35,105 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-08-11 |
4 |
AS |
$2.36 |
$1,610 |
D/D |
(682) |
32,814 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-08-11 |
4 |
OE |
$0.51 |
$1,171 |
D/D |
2,292 |
33,496 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-07-11 |
4 |
AS |
$2.34 |
$1,608 |
D/D |
(687) |
31,204 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-07-11 |
4 |
OE |
$0.51 |
$1,171 |
D/D |
2,292 |
31,891 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-06-12 |
4 |
AS |
$2.64 |
$1,610 |
D/D |
(610) |
29,599 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-06-12 |
4 |
OE |
$0.51 |
$1,171 |
D/D |
2,291 |
30,209 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-05-11 |
4 |
AS |
$2.89 |
$1,624 |
D/D |
(562) |
27,918 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-05-11 |
4 |
OE |
$0.51 |
$1,171 |
D/D |
2,291 |
28,480 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-04-11 |
4 |
AS |
$1.84 |
$1,545 |
D/D |
(840) |
26,189 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-04-11 |
4 |
OE |
$0.51 |
$1,171 |
D/D |
2,292 |
27,029 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-02-13 |
4 |
AS |
$2.45 |
$20,761 |
D/D |
(8,474) |
23,338 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-02-13 |
4 |
OE |
$0.51 |
$14,053 |
D/D |
27,500 |
31,812 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
